Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes

<i>FMR1</i> (FMRP translational regulator 1) variants other than repeat expansion are known to cause disease phenotypes but can be overlooked if they are not accounted for in genetic testing strategies. We collected and reanalyzed the evidence for pathogenicity of <i>FMR1</i>...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cedrik Tekendo-Ngongang, Angela Grochowsky, Benjamin D. Solomon, Sho T. Yano
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/6e7e7d6aa7194e14893eff7ca6a5b2b3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6e7e7d6aa7194e14893eff7ca6a5b2b3
record_format dspace
spelling oai:doaj.org-article:6e7e7d6aa7194e14893eff7ca6a5b2b32021-11-25T17:40:33ZBeyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes10.3390/genes121116692073-4425https://doaj.org/article/6e7e7d6aa7194e14893eff7ca6a5b2b32021-10-01T00:00:00Zhttps://www.mdpi.com/2073-4425/12/11/1669https://doaj.org/toc/2073-4425<i>FMR1</i> (FMRP translational regulator 1) variants other than repeat expansion are known to cause disease phenotypes but can be overlooked if they are not accounted for in genetic testing strategies. We collected and reanalyzed the evidence for pathogenicity of <i>FMR1</i> coding, noncoding, and copy number variants published to date. There is a spectrum of disease-causing <i>FMR1</i> variation, with clinical and functional evidence supporting pathogenicity of five splicing, five missense, one in-frame deletion, one nonsense, and four frameshift variants. In addition, <i>FMR1</i> deletions occur in both mosaic full mutation patients and as constitutional pathogenic alleles. De novo deletions arise not only from full mutation alleles but also alleles with normal-sized CGG repeats in several patients, suggesting that the CGG repeat region may be prone to genomic instability even in the absence of repeat expansion. We conclude that clinical tests for potentially <i>FMR1</i>-related indications such as intellectual disability should include methods capable of detecting small coding, noncoding, and copy number variants.Cedrik Tekendo-NgongangAngela GrochowskyBenjamin D. SolomonSho T. YanoMDPI AGarticle<i>FMR1</i>FMRPfragile Xvariant classificationcopy number variantsGeneticsQH426-470ENGenes, Vol 12, Iss 1669, p 1669 (2021)
institution DOAJ
collection DOAJ
language EN
topic <i>FMR1</i>
FMRP
fragile X
variant classification
copy number variants
Genetics
QH426-470
spellingShingle <i>FMR1</i>
FMRP
fragile X
variant classification
copy number variants
Genetics
QH426-470
Cedrik Tekendo-Ngongang
Angela Grochowsky
Benjamin D. Solomon
Sho T. Yano
Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes
description <i>FMR1</i> (FMRP translational regulator 1) variants other than repeat expansion are known to cause disease phenotypes but can be overlooked if they are not accounted for in genetic testing strategies. We collected and reanalyzed the evidence for pathogenicity of <i>FMR1</i> coding, noncoding, and copy number variants published to date. There is a spectrum of disease-causing <i>FMR1</i> variation, with clinical and functional evidence supporting pathogenicity of five splicing, five missense, one in-frame deletion, one nonsense, and four frameshift variants. In addition, <i>FMR1</i> deletions occur in both mosaic full mutation patients and as constitutional pathogenic alleles. De novo deletions arise not only from full mutation alleles but also alleles with normal-sized CGG repeats in several patients, suggesting that the CGG repeat region may be prone to genomic instability even in the absence of repeat expansion. We conclude that clinical tests for potentially <i>FMR1</i>-related indications such as intellectual disability should include methods capable of detecting small coding, noncoding, and copy number variants.
format article
author Cedrik Tekendo-Ngongang
Angela Grochowsky
Benjamin D. Solomon
Sho T. Yano
author_facet Cedrik Tekendo-Ngongang
Angela Grochowsky
Benjamin D. Solomon
Sho T. Yano
author_sort Cedrik Tekendo-Ngongang
title Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes
title_short Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes
title_full Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes
title_fullStr Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes
title_full_unstemmed Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes
title_sort beyond trinucleotide repeat expansion in fragile x syndrome: rare coding and noncoding variants in <i>fmr1</i> and associated phenotypes
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/6e7e7d6aa7194e14893eff7ca6a5b2b3
work_keys_str_mv AT cedriktekendongongang beyondtrinucleotiderepeatexpansioninfragilexsyndromerarecodingandnoncodingvariantsinifmr1iandassociatedphenotypes
AT angelagrochowsky beyondtrinucleotiderepeatexpansioninfragilexsyndromerarecodingandnoncodingvariantsinifmr1iandassociatedphenotypes
AT benjamindsolomon beyondtrinucleotiderepeatexpansioninfragilexsyndromerarecodingandnoncodingvariantsinifmr1iandassociatedphenotypes
AT shotyano beyondtrinucleotiderepeatexpansioninfragilexsyndromerarecodingandnoncodingvariantsinifmr1iandassociatedphenotypes
_version_ 1718412110594048000